The Center is establishing next-generation new drug platforms through research on core and source technologies, conducting studies on patient-customized precision medical technology about intractable diseases, reinforcing the global competitiveness of Korean medical, pharmaceutical, and biological technologies through research on rare diseases and infectious disease diagnosis and control technologies, forming an ecosystem for innovative new drug development, and increasing the publicity of new drug research.